|Bid||91.24 x 900|
|Ask||96.09 x 1000|
|Day's Range||93.65 - 95.43|
|52 Week Range||35.49 - 113.06|
|PE Ratio (TTM)||N/A|
|YTD Daily Total Return||6.82%|
|Beta (5Y Monthly)||1.95|
|Expense Ratio (net)||0.95%|
Marc Lichtenfeld, an expert in biotech and income stocks, notes that a lot of Wall Street money moves into companies that issue positive Phase 2 clinical trial data.
Nasdaq Stock Exchange President Nelson Griggs joins Yahoo Finance’s Seana Smith to discuss market operations amid the coronavirus and the outlook on IPOs.